公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2014 | Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving allogeneic hematopoietic stem cell transplantation | Yeh S.-P.; Lo W.-C.; Hsieh C.-Y.; Bai L.-Y.; Lin C.-C.; PO-HAN LIN ; Lin C.-Y.; Liao Y.-M.; Chiu C.-F. | Supportive Care in Cancer | 8 | 3 | |
2023 | Patients' attitudes regarding genetic counseling before germline BRCA1/2 pathogenic variants testing in Taiwan: A single-country, multi-center, patient-reported outcome study | Kuo, Wen-Ling; PO-HAN LIN ; Peng, Meng-Ting; Chu, Chia-Hui; Cho, Chia-Wei | Journal of Genetic Counseling | | | |
2017 | Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer | SUNG-HSIN KUO ; Yang S.-Y.; You S.-L.; HUANG-CHUN LIEN ; CHING-HUNG LIN ; PO-HAN LIN ; CHIUN-SHENG HUANG | Oncotarget | 35 | 30 | |
2013 | Prognostic analysis of adjuvant chemotherapy in patients with nasopharyngeal carcinoma | Lin C.-C.; Chen T.-T.; Lin C.-Y.; Hsieh C.-Y.; PO-HAN LIN ; Chien C.-R.; Chiu C.-F.; Yeh S.-P. | Future Oncology | 6 | 5 | |
2013 | Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3 | PO-HAN LIN ; Lin C.-C.; Yang H.-I.; Li L.-Y.; Bai L.-Y.; Chiu C.-F.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-Y.; Ho C.-M.; Yang S.-F.; Peng C.-T.; Tsai F.-J.; Yeh S.-P. | Leukemia Research | 34 | 31 | |
2011 | Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients? | CHING-HUNG LIN ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; KUAN-TING KUO ; Wang C.-C.; You S.-L.; PO-HAN LIN ; DWANG-YING CHANG ; WEN-HUNG KUO ; KING-JEN CHANG ; ANN-LII CHENG | Journal of Clinical Pathology | 8 | 8 | |
2018 | Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels | Kwong A.; Ho J.C.W.; Shin V.Y.; Kurian A.W.; Tai E.; Esserman L.J.; Weitzel J.N.; PO-HAN LIN ; Field M.; Domchek S.M.; Lo J.; Ngan H.Y.S.; Ma E.S.K.; Chan T.L.; Ford J.M. | Oncotarget | 7 | 0 | |
2021 | Reproductive and environmental exposures and the breast cancer risk in Taiwanese women | Wu, Hui-Chen; Yang, Hwai-I; PO-HAN LIN ; Chen, Chien-Jen; Santella, Regina M; Terry, Mary Beth | Scientific Reports | 4 | 3 | |
2014 | Safety and efficacy of pegylated liposomal doxorubicinbased adjuvant chemotherapy in patients with stage I-III triple-negative breast cancer | Lien M.-Y.; Liu L.-C.; Wang H.-C.; Yeh M.-H.; Chen C.-J.; Yeh S.-P.; Bai L.-Y.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-C.; Li L.-Y.; PO-HAN LIN ; Chiu C.-F. | Anticancer Research | 30 | 30 | |
2017 | A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice | PO-HAN LIN ; Li H.-Y.; Fan S.-C.; Yuan T.-H.; Chen M.; Hsu Y.-H.; Yang Y.-H.; Li L.-Y.; Yeh S.-P.; Bai L.-Y.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-C.; Lin C.-H.; Lien M.-Y.; Chen T.-T.; YEN-HSUAN NI ; Chiu C.-F. | Cancer Medicine | 47 | 41 | |
2020 | Using next-generation sequencing to redefine BRCAness in triple-negative breast cancer | PO-HAN LIN ; MING CHEN; TSAI, LI-WEI ; Chiao Lo ; Yen, Tzu-Chun; Huang, Thomas Yoyan; Chen, Chih-Kai; Fan, Sheng-Chih; SUNG-HSIN KUO ; CHIUN-SHENG HUANG | Cancer science | 30 | 25 | |
2019 | Varlitinib downregulates HER/ERK signaling and induces apoptosis in triple negative breast cancer cells | Liu C.-Y.; Chu P.-Y.; Huang C.-T.; Chen J.-L.; Yang H.-P.; Wang W.-L.; Lau K.-Y.; Lee C.-H.; Lan T.-Y.; Huang T.-T.; PO-HAN LIN ; Dai M.-S.; Tseng L.-M. | Cancers | 23 | 22 | |
2010 | Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation | PO-HAN LIN ; YEN-SHEN LU ; CHING-HUNG LIN ; DWANG-YING CHANG ; CHIUN-SHENG HUANG ; ANN-LII CHENG ; KUN-HUEI YEH | Anticancer Research | 6 | 4 | |